Deutsche Bank Ag\ Ideaya Biosciences, Inc. Transaction History

Deutsche Bank Ag\

$245 Billion
Q1 2025

A detailed history of Deutsche Bank Ag\ transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 467,461 shares of IDYA stock, worth $9.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

467,461

Previous 372,979 25.33%

Holding current value

$9.99 Million

Previous $9.59 Million 20.11%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$16.38 - $26.0 $1.55 Million - $2.46 Million	94,482 Added 25.33%	467,461 $7.66 Million
Q4 2024 Feb 14, 2025	BUY	$24.79 - $31.98 $600,041 - $774,075	24,205 Added 6.94%	372,979 $9.59 Million
Q3 2024 Jun 26, 2025	SELL	$30.37 - $43.05 $3.6 Million - $5.11 Million	-118,687 Reduced 25.39%	348,774 $11 Million
Q3 2024 Nov 13, 2024	BUY	$30.37 - $43.05 $394,870 - $559,736	13,002 Added 3.87%	348,774 $11 Million
Q2 2024 Jun 12, 2025	SELL	$34.37 - $43.46 $4.53 Million - $5.72 Million	-131,689 Reduced 28.17%	335,772 $11.8 Million
Q2 2024 Aug 14, 2024	BUY	$34.37 - $43.46 $1.06 Million - $1.34 Million	30,860 Added 10.12%	335,772 $11.8 Million
Q1 2024 Jun 02, 2025	SELL	$34.2 - $47.13 $5.56 Million - $7.66 Million	-162,549 Reduced 34.77%	304,912 $13.4 Million
Q1 2024 May 15, 2024	BUY	$34.2 - $47.13 $7.2 Million - $9.92 Million	210,544 Added 223.11%	304,912 $13.4 Million
Q4 2023 Feb 14, 2024	BUY	$24.59 - $35.83 $1.59 Million - $2.31 Million	64,459 Added 215.52%	94,368 $3.36 Million
Q3 2023 Nov 09, 2023	BUY	$21.07 - $29.77 $85,417 - $120,687	4,054 Added 15.68%	29,909 $806,000
Q2 2023 Aug 14, 2023	SELL	$13.33 - $25.53 $56,385 - $107,991	-4,230 Reduced 14.06%	25,855 $607,000
Q1 2023 May 15, 2023	BUY	$13.49 - $18.72 $148,336 - $205,845	10,996 Added 57.6%	30,085 $413,000
Q4 2022 Feb 13, 2023	BUY	$14.47 - $18.17 $51,426 - $64,576	3,554 Added 22.88%	19,089 $346,000
Q3 2022 Nov 14, 2022	SELL	$9.24 - $15.79 $22,000 - $37,595	-2,381 Reduced 13.29%	15,535 $232,000
Q2 2022 Aug 11, 2022	BUY	$8.28 - $13.88 $1,051 - $1,762	127 Added 0.71%	17,916 $247,000
Q1 2022 May 13, 2022	SELL	$11.18 - $24.02 $23,679 - $50,874	-2,118 Reduced 10.64%	17,789 $199,000
Q4 2021 Feb 11, 2022	BUY	$20.95 - $26.88 $22,269 - $28,573	1,063 Added 5.64%	19,907 $471,000
Q3 2021 Nov 04, 2021	BUY	$17.26 - $27.08 $37,644 - $59,061	2,181 Added 13.09%	18,844 $480,000
Q2 2021 Aug 11, 2021	BUY	$17.76 - $24.83 $112,509 - $157,298	6,335 Added 61.34%	16,663 $350,000
Q1 2021 May 13, 2021	SELL	$13.48 - $23.77 $13,304 - $23,460	-987 Reduced 8.72%	10,328 $242,000
Q4 2020 Feb 16, 2021	BUY	$12.17 - $17.52 $40,550 - $58,376	3,332 Added 41.74%	11,315 $158,000
Q3 2020 Nov 12, 2020	BUY	$11.22 - $14.46 $27,455 - $35,383	2,447 Added 44.2%	7,983 $100,000
Q2 2020 Aug 13, 2020	BUY	$3.59 - $18.57 $19,874 - $102,803	5,536 New	5,536 $79,000

Others Institutions Holding IDYA

# of Institutions

212

Shares Held

80.3M

Call Options Held

80.3K

Put Options Held

30.5K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.03B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account